Fox NewsHealth
New daily pill cuts repeat stroke risk by 26%
The Food and Drug Administration has approved Sunharbo, or asundexian, for preventing another stroke. It is the first approved factor XIa inhibitor for this use, and trials showed a 26 percent reduction in repeat risk, though limitations and risks remain.
This card is an AI-assisted summary of reporting published by Fox News. Read the original report before relying on it for medical, legal, financial, safety, or emergency decisions.